心臓停止: バクロフェン投与中断の珍しい合併症
Singh Karminder1, Arora Niraj1, Nattanmai Chandershekran Prem1
1Department of Neurocritical Care, University of Missouri Columbia School of Medicine, Columbia, MO, USA.
The Neurohospitalist
|August 29, 2025
まとめ
バクロフェンポンプの除去は,心停止を含む,まれだが重度の離脱を引き起こす可能性があります. バクロフェンポンプの再挿入なしでの パルスなしの電気活動の成功管理が示されています
科学分野:
- 神経学
- 薬理学について
- クリティカル ケア 医療
背景:
- バクロフェンは,GABAアゴニストであり,脊髄損傷患者の特に重症な症例は,内 (IT) ポンプによって管理されます.
- ITポンプを外した後の突然のバクロフェン離脱は,発作,精神病,自律的不安定性を含む深刻な症状を引き起こす可能性があります.
- バクロフェン離脱の合併症は稀ですが,以前はITポンプの置換もありました.
研究 の 目的:
- バクロフェンITポンプを外した後に, 脈動のない電気的活動 (PEA) の停止を報告する.
- ITポンプの再挿入なしでのバクロフェン離脱による心停止の成功管理を強調する.
- 長期にわたってITポンプを使用している患者のバクロフェン離脱に対する臨床的注意の重要性を強調する.
主な方法:
- 脊髄損傷と性を持つ33歳の男性は,傷の消化のためにバクロフェンITポンプを外した.
- 摘出後24~48時間で心血管の不安定性と変化が観察され,PEA停止に至った.
- 心肺蘇生 (CPR) が開始され,その後静脈内静止薬と経口バクロフェンとクローナゼパムの投与が開始されました.
主要な成果:
- 患者はPEA停止を経験し,3ラウンドのCPR後に自発循環 (ROSC) の回復を達成しました.
- 経口バクロフェンを含む保守的な治療で,ITポンプの再挿入なしに10日間で臨床的安定性が回復しました.
- 患者は機械呼吸器と鎮静剤から 離れることができました
結論:
- ITポンプを外した後のバクロフェン離脱の潜在的な合併症である.
- 経口薬による保守的な治療は,PEA停止を含む重度の離脱症状の解消に有効である.
- 医療従事者は,バクロフェンの離脱合併症に対する高い疑念のインデックスを維持する必要があります.
関連する概念動画
Cardiopulmonary Resuscitation IV: Pharmacological Management
75
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
75
Drug Delivery: Parenteral Route
827
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
827
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
557
Intravenous regional anesthesia or the Bier block technique is used to anesthetize a specific limb or extremity. It uses exsanguinated or blood-drained vessels to transport local anesthetics or LAs to the peripheral nerve trunks. Lidocaine without vasoconstrictors like epinephrine is most commonly used for this technique. Other drugs used are prilocaine, ropivacaine, and chloroprocaine. Bupivacaine is not recommended for this technique due to its high cardiac toxicity.
One of the advantages of...
One of the advantages of...
557
Local Anesthetics: Clinical Application as Spinal Anesthesia
772
Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
772
Skeletal Muscle Relaxants: Adverse Effects
468
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
468
Depolarizing Blockers: Pharmocokinetics
377
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
377


